164 related articles for article (PubMed ID: 24485022)
21. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
From AM; Al Badarin FJ; McDonald FS; Bartholmai BJ; Cha SS; Rihal CS
Circ Cardiovasc Interv; 2010 Aug; 3(4):351-8. PubMed ID: 20647563
[TBL] [Abstract][Full Text] [Related]
22. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
[TBL] [Abstract][Full Text] [Related]
23. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
[TBL] [Abstract][Full Text] [Related]
24. The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology?
Henry DA; Evans DB; Robertson J
Med J Aust; 1991 Jun; 154(11):766-72. PubMed ID: 1828529
[TBL] [Abstract][Full Text] [Related]
25. Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Eng J; Wilson RF; Subramaniam RM; Zhang A; Suarez-Cuervo C; Turban S; Choi MJ; Sherrod C; Hutfless S; Iyoha EE; Bass EB
Ann Intern Med; 2016 Mar; 164(6):417-24. PubMed ID: 26830055
[TBL] [Abstract][Full Text] [Related]
26. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
[TBL] [Abstract][Full Text] [Related]
27. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
[TBL] [Abstract][Full Text] [Related]
28. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Briguori C; Visconti G; Ricciardelli B; Condorelli G;
EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
[TBL] [Abstract][Full Text] [Related]
29. Renal safety of iodixanol.
McCullough PA
Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):655-61. PubMed ID: 17081087
[TBL] [Abstract][Full Text] [Related]
30. Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
Werner S; Bez C; Hinterleitner C; Horger M
PLoS One; 2020; 15(5):e0233433. PubMed ID: 32437415
[TBL] [Abstract][Full Text] [Related]
31. Nephrotoxic effects in high-risk patients undergoing angiography.
Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Berg KJ;
N Engl J Med; 2003 Feb; 348(6):491-9. PubMed ID: 12571256
[TBL] [Abstract][Full Text] [Related]
32. Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study.
From AM; Bartholmai BJ; Williams AW; McDonald FS
Acta Radiol; 2008 May; 49(4):409-14. PubMed ID: 18415784
[TBL] [Abstract][Full Text] [Related]
33. An economic evaluation of an abdominal aortic aneurysm screening program in Italy.
Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D
J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837
[TBL] [Abstract][Full Text] [Related]
34. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
[TBL] [Abstract][Full Text] [Related]
35. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.
Davenport MS; Khalatbari S; Cohan RH; Dillman JR; Myles JD; Ellis JH
Radiology; 2013 Sep; 268(3):719-28. PubMed ID: 23579046
[TBL] [Abstract][Full Text] [Related]
36. Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients: a systematic review and meta-analysis.
Zhao F; Lei R; Yang SK; Luo M; Cheng W; Xiao YQ; Li XW; Guo J; Duan SB
Cancer Imaging; 2019 Jun; 19(1):38. PubMed ID: 31215488
[TBL] [Abstract][Full Text] [Related]
37. Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized controlled trials.
Dong M; Jiao Z; Liu T; Guo F; Li G
J Nephrol; 2012; 25(3):290-301. PubMed ID: 22252847
[TBL] [Abstract][Full Text] [Related]
38. Incidence of nonconfounded post-computed tomography acute kidney injury in hospitalized patients with stable renal function receiving intravenous iodinated contrast material.
Moore A; Dickerson E; Dillman JR; Vummidi D; Kershaw DB; Khalatbari S; Davenport MS
Curr Probl Diagn Radiol; 2014; 43(5):237-41. PubMed ID: 24909428
[TBL] [Abstract][Full Text] [Related]
39. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
Davenport MS; Khalatbari S; Dillman JR; Cohan RH; Caoili EM; Ellis JH
Radiology; 2013 Apr; 267(1):94-105. PubMed ID: 23360737
[TBL] [Abstract][Full Text] [Related]
40. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]